74
Papers
SYNTHESIS
MS (EI, 70 eV): m/z (%) = 211 (14, M+), 196 (35), 100 (100), 56 (26),
41 (17).
IR (NaCl): n = 3076 (w), 2956 (s), 2928 (vs), 2853 (s), 2805 (s), 2784
(m), 2767 (m), 1641 (m), 1456 (s), 1120 (vs), 1012 (m), 909 (m),
865 cm–1 (m).
2,7-Dimethyl-1,8-di(4-morpholino)octane (4b) (1:1 mixture of two
diastereoisomers): 0.219 g (10%).
1H NMR (400 MHz, CDCl3): d = 0.88 (d, 3J = 6.8 Hz, 6H, CH3), 1.04
(m, 2H, MeCHCH2), 1.28 (m, 6H, MeCHCH2 and CH2), 1.63 (m, 2H,
CH), 2.05 (dd, 3J = 8.0 Hz, 2J = 12.0 Hz, 2H, NCH2CHMe), 2.14 (dd,
3J = 6.8 Hz, 2J = 12.0 Hz, 2H, NCH2CHMe), 2.37 [t*, 3J = 4.6 Hz, 8H,
N(CH2CH2)2O], 3.69 [t*, 3J = 4.6 Hz, 8H, N(CH2CH2)2O].
13C NMR (100 MHz, CDCl3): d = 18.2 and 18.2 (CH3); 27.2 and
27.3 (CH2); 29.8 and 29.8 (CH); 35.1 and 35.1 (MeCHCH2);
54.1 [N(CH2CH2)2O]; 66.1 and 66.1 (NCH2CHMe); 67.0
[N(CH2CH2)2O].
HRMS (C13H25NO): calc. 211.19362, found 211.1935.
4-(Non-8-enyl)morpholine (11b): 0.365 g (25 %).
1H NMR (400 MHz, CDCl3): d = 1.30 (m, 8H, CH2), 1.47 (m, 2H,
CH2), 2.03 (q, 3J = 6.8 Hz, 2H, CH2CH=CH2), 2.31 (t*, 3J = 7.8 Hz,
2H, NCH2CH2), 2.42 [m, 4H, N(CH2CH2)2O], 3.72 [t*, 3J = 4.7 Hz,
4H, N(CH2CH2)2O], 4.94 [dd, 3J(Z) = 10.3 Hz, 2J = 1.0 Hz, 1H,
CH=CH2], 4.98 [dd, 3J(E) = 17.2 Hz, 2J = 1.0 Hz, 1H, CH=CH2], 5.80
[ddt, 3J(E) = 17.2 Hz, 3J(Z) = 10.3 Hz, 3J = 6.8 Hz, 1H, CH=CH2].
13C NMR (100 MHz, CDCl3): d = 26.5 (CH2), 27.4 (CH2), 28.8
(CH2), 28.9 (CH2), 29.3 (CH2), 33.7 (CH2), 53.7 [N(CH2CH2)2O],
59.1 (NCH2CH2), 66.9 [N(CH2CH2)2O], 114.1 (CH=CH2), 139.0
(CH=CH2).
MS (EI, 70 eV): m/z (%) = 312 (67, M+), 282 (27), 126 (12), 100
(100), 86 (10), 56 (25), 42 (12).
IR (NaCl): n = 2956 (vs), 2928 (vs), 2853 (vs), 2805 (vs), 2767 (s),
2685 (m), 2656 (m), 1456 (s), 1445 (m), 1296 (m), 1273 (m), 1119
(vs), 1071 (m), 1035 (m), 1013 (s), 865 (s), 798 cm–1 (m).
C18H36N2O2 (312.5): calc. C, 69.2; H, 11.6; N, 9.0. Found C, 69. l; H,
l 1.8; N, 9.1.
MS (EI, 70 eV): m/z (%) = 211 (53, M+), 170 (8), 126 (6), 100 (100),
87 (32), 56 (55), 41 (48).
IR (NaCl): n = 3076 (w), 2928 (vs), 2854 (vs), 2806 (s), 2766 (m),
1641 (m), 1457 (m), 1446 (m), 1274 (m), 1137 (m), 1120 (vs), 910
(m), 867 cm–1 (m).
2-Methyl-1,9-di(4-morpholino)nonane (5b): 0.962 g (44%).
1H NMR (400 MHz, CDCl3): d = 0.87 (d, 3J = 6.5 Hz, 3H, CH3), 1.04
(m, 1H, MeCHCH2), 1.34 (m, 11H, CH2 and MeCHCH2), 1.62 (m,
1H, CH), 2.05 (dd, 3J = 8.0 Hz, 2J = 12.0 Hz, 1H, NCH2CHMe), 2.14
(dd, 3J = 6.8 Hz, 2J = 12.0 Hz, 1H, NCH2CHMe), 2.36 [m, 10H,
N(CH2CH2)2O and NCH2CHMe], 3.70 [m, 8H, N(CH2CH2)2O].
13C NMR (100 MHz, CDCl3): d = 18.1 (CH3), 26.4 (CH2), 26.8
(CH2), 27.4 (CH2), 29.4 (CH2), 29.7 (CH2), 29.7 (CH), 35.0 (CH2),
53.7 [N(CH2CH2)2O], 54.0 [N(CH2CH2)2O], 59.1 (NCH2CH2), 66.0
(NCH2CHMe), 66.8 [N(CH2CH2)2O].
C13H25NO (211.3): calc. C, 73.9; H, 11.9; N, 6.6. Found C, 73.6 %; H,
12.0; N, 6.7.
Entry 4, Table 2
The reaction of 1c (0.978 g, 7 mmol) with morpholine (1.307 g,
15 mmol) yielded 99 % of a mixture containing 3 regioisomers 4c, 5c
and 6c. Column chromatography on neutral alumina with a 2:1 mix-
ture of PE and MTBE led to the isolation of products.
MS (EI, 70 eV): m/z (%) = 312 (67, M+), 282 (35), 252 (12), 100
(100), 56 (30).
IR (NaCl): n = 2954 (s), 2928 (vs), 2853 (vs), 2805 (s), 2766 (m),
2685 (w), 2656 (w), 1456 (m), 1445 (m), 1297 (m), 1273 (m), 1119
(vs), 1071 (m), 1035 (m), 1013 (m), 865 (s), 798 cm–1.
C18H36N2O2 (312.5): calc. C, 69.2; H, 11.6; N, 9.0. Found C, 69.0; H,
11.9; N, 8.9.
2,5-Dimethyl-1,6-di(4-morpholino)decane (4c) (1:1 mixture of two
diastereoisomers): 0.367 g (15 %).
1H NMR (400 MHz. CDCl3): d = 0.88 (d, 3J = 6.5 Hz, 6H, CH3), 1.05
(m, 2H, MeCHCH2), 1.29 (m, 10H, MeCHCH2 and CH2), 1.62 (m,
2H, CH), 2.04 (dd, 3J = 7.8 Hz, 2J = 12.0 Hz, 2H, NCH2CHMe), 2.16
(dd, 3J = 6.8 Hz, 2J = 12.0 Hz, 2H, NCH2CHMe), 2.37 (t*, 3J = 4.6 Hz,
8H, N[CH2CH2)2O], 3.69 [t*, 3J = 4.6 Hz, 8H, N(CH2CH2)2O].
13C NMR (100 MHz, CDCl3): d = 18.1 (CH3), 26.8 (CH2), 29.7 (CH),
29.8 (CH2), 35.0 (CH2), 54.0 [N(CH2CH2)2O], 66.0 (2´
NCH2CHMe), 66.9 [N(CH2CH2)2O].
1,10-Di(4-morpholino)decane (6b): 1.006 g (46 %).
1H NMR (400 MHz, CDCl3): d = 1.28 (m, 12H, CH2), 1.48 (m, 4H,
CH2), 2.31 (dd, 3J = 7.5 Hz, 3J = 6.0 Hz, 4H, NCH2CH2), 2.43 [m, 8H,
N(CH2CH2)2O], 3.72 [t*, 3J = 7.5 Hz, 8H, N(CH2CH2)2O].
13C NMR (100 MHz, CDCl3): d = 26.5 (CH2), 27.5 (CH2), 29.5
(CH2), 29.5 (CH2), 53.8 [N(CH2CH2)2O], 59.2 (NCH2CH2), 67.0
[N(CH2CH2)2O].
MS (EI, 70 eV): m/z (%) = 340 (66, M+), 310 (51), 280 (27), 224 (6),
196 (7), 140 (8), 126 (13), 100 (100), 86 (21), 72 (44), 56 (64), 41 (43).
IR (NaCl): n = 2954 (s), 2926 (vs), 2852 (vs), 2805 (vs), 2766 (m),
2685 (m), 1456 (s), 1273 (m), 1120 (vs), 865 cm–1 (m).
C20H40N2O2 (340.5): calc. C, 70.5; H, 11.8; N, 8,2. Found C, 70.5; H,
11.9; N, 8.1.
MS (EI, 70 eV): m/z (%) = 312 (75, M+), 282 (40), 252 (12), 100
(100), 72 (10), 56 (8).
IR (KBr): n = 2971 (m), 2952 (m), 2925 (vs), 2910 (s), 2867 (m),
2847 (s), 2811 (m), 2766 (m), 1465 (m), 1452 (m), 1277 (m), 1133
(m), 1114 (vs), 1015 (m), 868 cm–1(s).
2-Methyl-1,7-di(4-morpholino)undecane (5c): 1.286 g (54%).
1H NMR (400 MHz, CDCl3): d = 0.87 (d, 3J = 6.5 Hz, 3H, CH3), 1.05
(m, 1H, MeCHCH2), 1.35 (m, 15H, MeCHCH2 and CH2), 1.63 (m,
1H, CH), 2.04 (dd, 3J = 8.0 Hz, 2J = 12.0 Hz, 1H, NCH2CHMe), 2.14
(dd, 3J = 6.8 Hz, 2J = 12.0 Hz, 1H, NCH2CHMe), 2.32 [m, 10H,
C18H36N2O2 (312.5): calc. C, 69.2; H, 11.6; N, 9.0. Found C, 68.8; H,
11.9; N, 8.9.
Entry 3, Table 2
The reaction of 1b (0.771 g, 7 mmol) with morpholine (1.307 g,
l5 mmol) at a temperature of 80 °C instead of 120 °C yielded 84 % of
a mixture containing the 3 regioisomers 4b, 5b and 6b and in addition
10b and 11b. Column chromatography on neutral alumina with a
l5:1 mixture of PE and MTBE led to the isolation of products.
N(CH2CH2)2O, NCH2CH2], 3.67 [t*, 3J
=
4.0 Hz, 4H,
N(CH2CH2)2O], 3.69 [t*, 3J = 4.8 Hz, 4H, N(CH2CH2)2O].
13C NMR (100 MHz, CDCl3): d = 18.0 (CH3), 26.3 (CH2), 26.6
(CH2), 26.7 (CH2), 27.2 (CH2), 29.3 (CH2), 29.3 (CH2), 29.5 (CH),
29.6 (CH2), 34.8 (CH2), 53.5 [N(CH2CH2)2O], 53.8 [N(CH2CH2)2O],
58.9 (NCH2CH2), 65.9 (NCH2CHMe), 66.6 [N(CH2CH2)2O], 66.7
[N(CH2CH2)2O].
4-(2-Methyloct-7-enyl)morpholine (10b): 0.286 g (19 %).
1H NMR (400 MHz, CDCl3): d = 0.88 (d, 3J = 6.7 Hz, 3H, CH3), 1.07
(m, 1H, MeCHCH2), 1.34 (m, 5H, MeCHCH2 and CH2), 1.63 (m, 1H,
CH), 2.05 (m, 3H, H2C=CHCH2, NCH2CHMe), 2.14 (dd, 3J = 6.7 Hz,
2J = 12.0 Hz, 1H, NCH2CHMe), 2.37 (m, 4H, N(CH2CH2)2O), 3.70
(t*, 3J = 4.7 Hz, 4H, N(CH2CH2)2O), 4.94 [dd, 3J(Z) = 10.2 Hz, 2J =
MS (EI, 70 eV): m/z (%) = 340 (41, M+), 310 (24), 280 (8), 100 (100),
72 (5), 56 (6).
IR (KBr): n = 2995 (m), 2916 (vs), 2849 (vs), 2766 (m), 2735 (m),
1456 (s), 1273 (s), 1118 (vs), 1015 (vs), 865 cm–1 (vs).
C20H40N2O2 (340.5): calc. C, 70.5; H, 11.8; N, 8.2. Found C, 70.8; H,
11.8; N, 8.1.
3
2
1.2 Hz, 1H, CH=CH2], 4.98 [dd, J(E) = 17.2 Hz, J = 1.2 Hz, 1H,
CH=CH2], 5.82 [ddt, 3J(E) = 17.2 Hz, 3J(Z) = 10.2 Hz, 3J = 6.6 Hz,
1H, CH=CH2].
13C NMR (100 MHz, CDCl3): d = 18.2 (CH3), 26.4 (CH2), 29.2
(CH2), 29.8 (CH), 33.8 (CH2), 34.9 (CH2), 54.1 [N(CH2CH2)2O],
66.1 (NCH2CHMe), 67.0 [N(CH2CH2)2O], 114.2 (CH=CH2), 139.0
(CH=CH2).
1,8-Di(4-morpholino)dodecane (6c): 0.731 g (30 %).
1H NMR (400 MHz, CDCl3): d = 1.26 (m, 16H, CH2), 1.48 (m, 4H,
CH2), 2.31 (t*, 3J = 7.8 Hz, 4H, NCH2CH2), 2.43 [m, 8H,
N(CH2CH2)2O], 3.72 [t*, 3J = 4.5 Hz, 8H, N(CH2CH2)2O].